| SARS-COV-2 | Severe acute respiratory syndrome coronavirus 2 |
| COVID-19 | Coronavirus Disease 2019 |
| ICU | Intensive Care Unit |
| ECMO | extracorporeal membrane oxygenation |
| NSAIDs | Nonsteroidal anti-inflammatory drugs |
| CPOT | Critical Care Pain Observation Tool |
| BPS | Behavioral Pain Scale |
| WHO | World Health Organization |
| RNA | ribonucleic acid |
| SARS | Severe Acute Respiratory Syndrome |
| MERS | Middle East Respiratory Syndrome |
| et al. | et alia |
| PNS | peripheral nervous system |
| CNS | Central nervous system |
| IL | Interleukin |
| ACE2 | Angiotensin-converting enzyme 2 |
| ANG | Angiotensin |
| TNF | tumor necrosis factor |
| PGE2 | Prostaglandin E2 |
| CSF | Cerebrospinal Fluid |
| TG | Trigeminal ganglia |
| CGRP | calcitonin gene-related peptide |
| VAS | visual analogue scale |
| NRS | numerical assessment scale |
| NMB | neuromuscular blocking medications |
| CoVs | Coronaviruses |
| COPD | chronic obstructive pulmonary disease |
| NK | Natural Killer cells |
| RR | Relative risk |
| COX | cyclooxygenase |
| LOX | lipoxygenase |
| EMA | European Medicines Agency |
| OCT | Over-the-counter drug |
| ASA | acetylsalicylic acid |
| NNT | numbers needed to treat |